These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Induction of granulocyte-macrophage colony-stimulating activity by 12-O-tetradecanoylphorbol-13-acetate in SENCAR and B6C3F1 mice.
    Author: Updyke LW, Yoon HL, Pfeifer RW.
    Journal: Carcinogenesis; 1991 Apr; 12(4):735-9. PubMed ID: 2013137.
    Abstract:
    Previous studies in this laboratory and others have indicated that 12-O-tetradecanoylphorbol-13-acetate (TPA), the most potent skin tumor promoter known, evokes significantly greater inflammatory responses in phorbol ester-sensitive (SENCAR) mice compared to strains (e.g. C57BL/6 and B6C3F1) that are relatively resistant to the outgrowth of skin tumors in two-stage chemically induced carcinogenesis protocols. In the studies reported herein, subchronic topical application of TPA at doses relevant to two-stage protocols induced serum granulocyte-macrophage colony-stimulating activity (GM-CSA) in both SENCAR and B6C3F1 mice; however, the increase in SENCAR mice was significantly greater than that observed in the relatively resistant B6C3F1 strain (5-fold versus a 2-fold increase respectively). The greater increase in serum GM-CSA observed in SENCAR mice was correlated with a 31% increase in the number of splenic leukocytes that lacked both B and T cell surface markers (i.e. double-negative cells), a presumed GM progenitor cell; no significant increase in the relative percentage of such cells was observed in B6C3F1 mice. Alternatively, significant decreases in splenic T lymphocytes (23 and 32% in SENCAR and B6C3F1 respectively) were observed in both strains of TPA-treated mice and may, in part, account for the previously observed decreases in splenic cell blastogenic response to the T cell mitogen phytohemagglutinin (PHA). In vitro incubation of splenic cells from SENCAR mice with 0.01-1.0 microM TPA led to significantly greater increases in colony formation relative to splenic cells isolated from B6C3F1 mice; therefore, differences in the biochemical responsiveness between strains may occur at the level of signal transduction in splenic GM progenitor cells. In conclusion, these studies indicated that strain-dependent differences in the systemic inflammatory response following topical application of TPA may result from direct stimulation of splenic GM precursor cells by TPA and/or may occur, indirectly, through the release of cytokines [e.g. GM colony-stimulating factor (GM-CSF)] by induced epidermal (or other) cells.
    [Abstract] [Full Text] [Related] [New Search]